Investigation of Plasma Preseptin (sCD14-ST) Levels in Sepsis
scd14-st
sepsis
presepsin
R
biomarker
Medicine
Infectious and parasitic diseases
RC109-216
cd14
DOI:
10.4274/mjima.galenos.2021.2021.11
Publication Date:
2022-01-17T14:46:43Z
AUTHORS (3)
ABSTRACT
Introduction: In the recent years, presepsin has been defined as a biomarker useful in the early diagnosis of sepsis. We aimed to evaluate the diagnostic and prognostic value of presepsin in patients with a Systemic inflammatory response syndrome (SIRS) and sepsis. Materials and Methods: Totally 65 patients (42 patients diagnosed with the SIRS, sepsis, or septic shock, and 23 healthy controls) were included in this prospective case-control study. Results: On the first day of hospitalization, the median value of presepsin [687.5 pg/ml (115-10049 pg/ml)] in the patient group was significantly higher than the control group [71.5 pg/ml (44.1-170 pg/ml)] (p<0.001). In the sepsis and septic shock groups, presepsin levels were higher than the SIRS group (p1=0.002, p2=0.001). There was a positive correlation between the disease severity and presepsin on the first day of hospitalization and second day of the treatment (r=0.448, 0.423; p<0.001, p<0.001, respectively). When the cut-off value of presepsin was taken as 124 pg/ml for SIRS, sepsis, and septic shock for the first day of hospitalization, the sensitivity was 97.6% and the specificity was 95.7% [area under the curve (AUC): 0.996 (p<0.001)]. When the cut-off value of the presepsin on admission was 439 pg/ml, the sensitivity of the presepsin was 100% and the specificity was 57.1% in separating a sepsis from the SIRS cases [AUC: 0.772 (p<0.001)]. When the threshold level of presepsin was taken as 864 pg/ml on the first day of hospitalization, septic shock was distinguished from the sepsis and SIRS cases with 100% sensitivity and 69.4% specificity [AUC: 0.856 (p<0.001)]. Conclusion: Presepsin appears to be a useful biomarker in early diagnosis of the SIRS, sepsis, and septic shock patients in where a rapid diagnosis and treatment are known to be lifesaving.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....